TY - JOUR
T1 - ZEB2 is a master switch controlling the tumor-associated macrophage program
AU - Sheban, Fadi
AU - Phan, Truong San
AU - Xie, Ken
AU - Ingelfinger, Florian
AU - Gur, Chamutal
AU - Shapir Itai, Yuval
AU - Blecher-Gonen, Ronnie
AU - Yu, Chunsong
AU - Avellino, Roberto
AU - Chalan, Paulina
AU - Freitag, Kiara
AU - Yofe, Ido
AU - Yutkin, Vladimir
AU - Boyeau, Pierre
AU - Ergen, Can
AU - Hong, Justin
AU - Mazuz, Kfir
AU - Liu, Yuxiao
AU - Chen, Kangming
AU - Dahan, Rony
AU - Kortylewski, Marcin
AU - Yosef, Nir
AU - Weiner, Assaf
AU - Amit, Ido
N1 - Publisher Copyright: © 2025 Elsevier Inc.
PY - 2025/4/10
Y1 - 2025/4/10
N2 - Tumor-associated macrophages (TAMs) are key mediators of tumor immune evasion. However, their regulatory circuits and checkpoints are partially understood. Here, we generated a TAM regulatory network by integrating human tumors single-cell RNA sequencing (scRNA-seq) data with a dedicated CRISPR screen. Using a deep generative model, we constructed a gene perturbation network linking individual candidates with prototypical TAM functions. We identified Zeb2 as the master regulator of TAM programs, orchestrating suppression of type-I interferon response and antigen presentation alongside activation of immune suppression programs. Genetic ablation of ZEB2 reprograms TAM function and identity on the chromatin, RNA, and protein levels. In macrophage-rich human tumors, ZEB2 expression is associated with poor prognosis. Selective Zeb2 in vivo targeting reprograms TAMs and mobilizes systemic T cell responses, achieving robust tumor clearance. Overall, our study generates a detailed roadmap of TAM gene circuits and identifies ZEB2 as a master switch with therapeutic potential.
AB - Tumor-associated macrophages (TAMs) are key mediators of tumor immune evasion. However, their regulatory circuits and checkpoints are partially understood. Here, we generated a TAM regulatory network by integrating human tumors single-cell RNA sequencing (scRNA-seq) data with a dedicated CRISPR screen. Using a deep generative model, we constructed a gene perturbation network linking individual candidates with prototypical TAM functions. We identified Zeb2 as the master regulator of TAM programs, orchestrating suppression of type-I interferon response and antigen presentation alongside activation of immune suppression programs. Genetic ablation of ZEB2 reprograms TAM function and identity on the chromatin, RNA, and protein levels. In macrophage-rich human tumors, ZEB2 expression is associated with poor prognosis. Selective Zeb2 in vivo targeting reprograms TAMs and mobilizes systemic T cell responses, achieving robust tumor clearance. Overall, our study generates a detailed roadmap of TAM gene circuits and identifies ZEB2 as a master switch with therapeutic potential.
UR - http://www.scopus.com/inward/record.url?scp=105002806632&partnerID=8YFLogxK
U2 - 10.1016/j.ccell.2025.03.021
DO - 10.1016/j.ccell.2025.03.021
M3 - مقالة
SN - 1535-6108
JO - Cancer Cell
JF - Cancer Cell
ER -